ZYBERNO
Stock Report
Updated Aug 31, 2026

EXAGEN INC. (XGN)

Healthcare • NASDAQ

$7.36

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
18.0/100
POOR BUSINESS
EXAGEN INC. (XGN) scores 18/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-121.6%)
Debt-to-Equity (Solvency Risk):CRITICAL (2.04x)
Operating Margin (Operational Efficiency):CRITICAL (-18.6%)
Return on Capital (Capital Efficiency):CRITICAL (-73.9%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

EXAGEN INC. (XGN) stock report — Zyberno Score 18/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, XGN generated -$14.13M in Owner Earnings. Capital was deployed as follows: $756.00K invested in capital expenditures. Reinvestment rate: 14.7%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:7.36
Market Cap:$177.85M

Valuation Multiples (3)

P/B Ratio:14.56x
P/S Ratio:2.50x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$179.04M

Price Action & Momentum (3)

Momentum Percentile:15 / 100
% of 52-Week High:60.2%
B. Profitability Assessment

Return Metrics (5)

ROA:-33.7%
Reinvestment Rate:14.7%
Fundamental Growth Rate (g):-10.9%

Margin Analysis (3)

Operating Margin Ttm:-18.6%
Net Margin Ttm:-26.6%
Ebitda Margin:-15.2%

TTM Performance (3)

Gross Margin Ttm:58.6%
Operating Margin Ttm:-18.6%
Net Margin Ttm:-26.6%

Yield Metrics (2)

Earnings Yield:-$12.46
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:2.8%
Latest Earnings Filed:2026-08-04

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):10.2%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:3.18x
Quick Ratio:3.18x
Cash Ratio:1.83x

Leverage Analysis (3)

Debt To Equity Ttm:2.04x
Debt-to-Equity Ratio:2.04x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-2.75x
Times Interest Earned:-2.75

Capital Structure (4)

Working Capital:29,400,000.00
Cash And Cash Equivalents:24,588,000.00
Long Term Debt:$22.32M
Net Debt:$1.18M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $71.12M
Linear Growth: 10.2%
📊 Click to view full XGN Revenue analysis & methodology →
Cost Of Revenue Ttm:$29.42M

Profitability Breakdown (2)

Gross profit TTM: $41.70M
Linear Growth: 16.2%
📊 Click to view full XGN Gross Profit analysis & methodology →
-$13.21M

Bottom Line Performance (3)

-$18.92M
Income Before Tax:$0.00
Ebitda Ttm:-10,811,000.00

Operating Expenses (5)

Operating Expenses:54,914,000.00
R And D Expense:6,466,000.00
Sga Expense:48,448,000.00
Income Tax Expense:$74.00K
Interest Expense:5,117,000.00

Expense Ratios (3)

R And D To Revenue Percentage:32.4%
Sga To Revenue Percentage:243.0%
Ebitda Margin:-15.2%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$51.94M
Current Assets:$42.86M
Ppe Net:0.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:39,719,000.00
Current Liabilities:13,457,000.00
Long Term Debt:$22.32M
Short Term Debt:$3.45M

Equity & Capital (3)

Equity:$12.22M
Retained Earnings:-$321.45M
Common Stock:200,000,000.00

Working Capital Items (3)

Accounts Receivable:12,407,000.00
Inventory:0.00
Accounts Payable:4,439,000.00

Special Items (2)

Contract Liabilities:1,500,000.00
Stock Based Compensation:980,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$13.37M-$14.13M

Investment Activities (2)

Investing Cash Flow:-$228.00K
Capital Expenditures Ttm:756,000.00

Financing Activities (3)

Financing Cash Flow:-$62.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:2,400,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.82
-$0.82
Earnings Per Share Ttm:-$0.78

Revenue & Cash Per Share (2)

Sales Per Share Ttm:2.94
Operating Cash Flow Per Share:-$0.56

Book Value & Capital (2)

Book Value Per Share:$0.51
Cash Per Share:1.02

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:1.27x
Working Capital Turnover Ttm:2.42x

Receivables Management (2)

Receivables Turnover Ttm:5.73x
Days Sales Outstanding Ttm:63.67

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:55.07
Cash Conversion Cycle:-990.40
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:40.00
Quality Score:25.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$14.13M

Damodaran Growth Analysis (2)

Reinvestment Rate:14.7%
Fundamental Growth Rate (g):-10.9%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):10.2%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):16.2%
Book Value Growth Rate (Linear):-34.2%
C. Company Profile & Context

Corporate Information (6)

Symbol:XGN
Company Name:EXAGEN INC.
Sector:Healthcare
Industry:Services-Medical Laboratories
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:24.16M
Shares Outstanding Basic:24.16M
Shares Outstanding Diluted:24.16M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-31 17:26:58 UTC
Data Timestamp:2026-08-19T15:50:54.837675
Scroll to Top